BIOMAT Database Logo BIOMAT Database Logo

c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. 2006

Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Divisions of Vascular Surgery and Cardiac Surgery, Toronto General Hospital Research Institute of the University Health Network, University of Toronto, Toronto, Ontario M5G-2C4, Canada.

Microsomal prostaglandin (PG) E(2) synthase-1 (mPGES-1) catalyzes the terminal step in the biosynthesis of PGE(2), a key proinflammatory mediator. The purpose of this study was to elucidate the regulation of mPGES-1 mRNA expression in cardiomyocytes, define the role of JNK enzymes in this process, and characterize the role of mPGES-1 in cardiomyocyte PGE(2) biosynthesis. In neonatal cardiomyocytes, interleukin-1beta and lipopolysaccharide (LPS) both stimulated mPGES-1 mRNA expression and increased mPGES-1 mRNA stability and protein synthesis but failed to increase mPGES-1 mRNA transcription. Treatment with the JNK1/2 inhibitor, SP600125, abrogated the increases in mPGES-1 mRNA stability, mPGES-1 protein synthesis, and PGE(2) release induced by interleukin-1beta or LPS. mPGES-1 protein synthesis was observed in LPS-stimulated neonatal cardiomyocytes from jnk1(-/-) or jnk2(-/-) mice. In contrast, infection of jnk1(-/-) cardiomyocytes with an adenovirus encoding phosphorylation-resistant JNK2 (ad-JNK2-DN), or of jnk2(-/-) cardiomyocytes with ad-JNK1-DN, significantly decreased LPS-stimulated mPGES-1 protein synthesis. Similarly, co-infection with ad-JNK1-DN and ad-JNK2-DN attenuated LPS-stimulated mPGES-1 protein synthesis in cardiomyocytes from wild type mice. Targeted deletion of the gene encoding mPGES-1 led to a 3.2-fold decrease in LPS-stimulated PGE(2) release by cardiomyocytes in comparison with wild type cells but had no effect on COX-1, COX-2, mPGES-2, or cytosolic PGES mRNA levels. These studies provide direct evidence that mPGES-1 mRNA levels in cardiomyocytes are augmented by stabilization of mPGES-1 mRNA, that JNK1 or JNK2 can participate in the regulation of mPGES-1 protein synthesis in these cells, and that mPGES-1 catalyzes the majority of LPS-induced PGE(2) biosynthesis by cardiomyocytes.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D003609 Dactinomycin A compound composed of a two CYCLIC PEPTIDES attached to a phenoxazine that is derived from STREPTOMYCES parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015) Actinomycin,Actinomycin D,Meractinomycin,Cosmegen,Cosmegen Lyovac,Lyovac-Cosmegen,Lyovac Cosmegen,Lyovac, Cosmegen,LyovacCosmegen
D000071876 Prostaglandin-E Synthases Oxidoreductases that catalyze the GLUTATHIONE-dependent oxidoreduction of PROSTAGLANDIN H2 to PROSTAGLANDIN E2. Cytosolic Prostaglandin E2 Synthase,Endoperoxide Isomerase,PGE2 Isomerase,PGE2 Synthase,PGR2 E-Isomerase,PTGES2 Protein,PTGES3 Protein,Prostaglandin E Isomerase,Prostaglandin E Synthase,Prostaglandin E Synthase 1,Prostaglandin E Synthase 2,Prostaglandin E Synthase 3,Prostaglandin E Synthase-1,Prostaglandin E Synthases,Prostaglandin E2 Synthase,Prostaglandin Endoperoxide E Isomerase,Prostaglandin H2 E-Isomerase,Prostaglandin H2-Prostaglandin E2 Isomerase,Prostaglandin R2 E-Isomerase,Prostaglandin-E Synthase,E Synthases, Prostaglandin,Isomerase, Endoperoxide,Isomerase, PGE2,Isomerase, Prostaglandin E,PGR2 E Isomerase,Prostaglandin H2 E Isomerase,Prostaglandin H2 Prostaglandin E2 Isomerase,Prostaglandin R2 E Isomerase,Synthase, PGE2,Synthase, Prostaglandin E,Synthase, Prostaglandin E2,Synthase, Prostaglandin-E,Synthases, Prostaglandin E,Synthases, Prostaglandin-E
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor.
November 1995, The Journal of biological chemistry,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1.
August 2009, Molecular cancer therapeutics,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
c-Jun N-terminal kinase regulates CTP:phosphocholine cytidylyltransferase.
March 2006, Archives of biochemistry and biophysics,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.
June 1998, Science (New York, N.Y.),
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1.
May 2007, Experimental biology and medicine (Maywood, N.J.),
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Prostaglandin E2 produced by microsomal prostaglandin E synthase-1 regulates the onset and the maintenance of wakefulness.
November 2011, Neurochemistry international,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
CREB-dependent cyclooxygenase-2 and microsomal prostaglandin E synthase-1 expression is mediated by protein kinase C and calcium.
August 2006, Journal of cellular biochemistry,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2.
January 2005, Arthritis research & therapy,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
c-Jun N-terminal kinase 2 suppresses pancreatic cancer growth and invasion and is opposed by c-Jun N-terminal kinase 1.
January 2022, Cancer gene therapy,
Norbert Degousee, and Denis Angoulvant, and Shafie Fazel, and Eva Stefanski, and Sipra Saha, and Karina Iliescu, and Thomas F Lindsay, and Jason E Fish, and Philip A Marsden, and Ren-Ke Li, and Laurent P Audoly, and Per-Johan Jakobsson, and Barry B Rubin
Regulation of p73-mediated apoptosis by c-Jun N-terminal kinase.
August 2007, The Biochemical journal,
Copied contents to your clipboard!